AAV8-delivered broadly neutralizing HIV antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AAV8-delivered broadly neutralizing HIV antibody, covering 2023-10-25 to 2023-10-25. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living With HIV: a Phase 1, Dose-escalation Trial [Phase 1]